Generalized pairwise comparisons for censored data: an overview

V Deltuvaite‐Thomas, J Verbeeck… - Biometrical …, 2023 - Wiley Online Library
The method of generalized pairwise comparisons (GPC) is an extension of the well‐known
nonparametric Wilcoxon–Mann–Whitney test for comparing two groups of observations …

Win odds: an adaptation of the win ratio to include ties

E Brunner, M Vandemeulebroecke… - Statistics in …, 2021 - Wiley Online Library
The win ratio, a recently proposed measure for comparing the benefit of two treatment
groups, allows ties in the data but ignores ties in the inference. In this article, we highlight …

The win odds: statistical inference and regression

J Song, J Verbeeck, B Huang, DC Hoaglin… - Journal of …, 2023 - Taylor & Francis
Generalized pairwise comparisons and win statistics (ie, win ratio, win odds and net benefit)
are advantageous in analyzing and interpreting a composite of multiple outcomes in clinical …

Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time‐to‐event outcomes

G Dong, B Huang, J Verbeeck, Y Cui… - Pharmaceutical …, 2023 - Wiley Online Library
Conventional analyses of a composite of multiple time‐to‐event outcomes use the time to
the first event. However, the first event may not be the most important outcome. To address …

On recurrent-event win ratio

L Mao, KM Kim, Y Li - Statistical methods in medical …, 2022 - journals.sagepub.com
The win ratio approach proposed by Pocock et al.(2012) has become a popular tool for
analyzing composite endpoints of death and non-fatal events like hospitalization. Its …

Adjusting win statistics for dependent censoring

G Dong, B Huang, D Wang, J Verbeeck… - Pharmaceutical …, 2021 - Wiley Online Library
For composite outcomes whose components can be prioritized on clinical importance, the
win ratio, the net benefit and the win odds apply that order in comparing patients pairwise to …

Adjusted win ratio using the inverse probability of treatment weighting

D Wang, S Zheng, Y Cui, N He, T Chen… - Journal of …, 2023 - Taylor & Francis
The win ratio method has been increasingly applied in the design and analysis of clinical
trials. However, the win ratio method is a univariate approach that does not allow for …

Use of Win Statistics to Analyze Outcomes in the DAPA-HF and DELIVER Trials

T Kondo, SB Gasparyan, PS Jhund… - NEJM …, 2023 - evidence.nejm.org
Background The primary end point in most heart failure (HF) trials is a composite of time to a
first worsening HF event or cardiovascular death. Prevention of recurrent events and …

On restricted mean time in favor of treatment

L Mao - Biometrics, 2023 - Wiley Online Library
The restricted mean time in favor (RMT‐IF) of treatment is a nonparametric effect size for
complex life history data. It is defined as the net average time the treated spend in a more …

[HTML][HTML] Target Trial Emulation: Does surgical versus non-surgical management of cranial cruciate ligament rupture in dogs cause different outcomes?

C Pegram, K Diaz-Ordaz, DC Brodbelt… - Preventive Veterinary …, 2024 - Elsevier
Target trial emulation applies design principles from randomised controlled trials to the
analysis of observational data for causal inference and is increasingly used within human …